Individual and Family Discount Dental Plans, Affordable
Dental Care Starting at $79.95 a Year!
1-888-632-5353 
M-F 8 AM - 9 PM EST 

Find Plans in Your Area
 
ZIP code
 

Find Dentists in Your Area
 
ZIP code
 
Dentist last name
(optional)
 




you are here: DentalPlans.com > Dental Health Articles > Cancer > Gene Variation Linked to Neuroblastoma a Childhood Cancer

Gene Variation Linked to Neuroblastoma, a Childhood Cancer
The variant is common in the aggressive form of the disease, researchers report
By Steven Reinberg
HealthDay Reporter
Updated: 5/7/2008 6:00:27 PM
 

WEDNESDAY, May 7 (HealthDay News) -- For the first time, a gene linked to the often fatal childhood cancer neuroblastoma has been identified, researchers report.

"This is the first paper that helps us understand what causes this childhood cancer," said lead researcher Dr. John M. Maris, director of the Center for Childhood Cancer Research at The Children's Hospital of Philadelphia. "We expected for decades that this cancer was a genetic disease, but we have had a hard time understanding what abnormalities in our genetic makeup lead to this cancer."

Neuroblastoma, a cancer of the peripheral nervous system that usually appears as a solid tumor in the chest or abdomen, is the most common solid tumor malignancy seen in early childhood. Among infants, it can disappear with minimal treatment, but in older children, it can be an aggressive cancer spreading throughout the body. Neuroblastoma accounts for 7 percent of all childhood cancers but causes 15 percent of all childhood cancer deaths. There are about 700 new cases diagnosed each year in the United States, the researchers said.

Maris' team found a common genetic variation of the gene 6p22 on chromosome 6, which doubles the risk of getting this disease. "This finding supports our assumption that there are a number of minor variations that work together -- in sort of a perfect storm -- to give a child this disease," he said. "This finding is the discovery of the first of these genetic variants."

Maris noted that this is the first time a childhood cancer has been found to be influenced by rather common genetic changes "that can be in you or me or anyone."

In addition, Maris said that having this particular genetic variation not only increases the risk of developing neuroblastoma, but also increases the risk of developing the more aggressive form of the disease. "This leads us to believe that the disease we call high-risk or low-risk neuroblastoma are really different diseases," he said.

The findings were published in the May 7 online edition of the New England Journal of Medicine.

For the study, Maris' team analyzed blood samples from 1,032 children with neuroblastoma and 2,043 children without the disease. The researchers honed in on three single nucleotide polymorphisms (SNPs) -- which are variations in DNA -- that were more common in patients with neuroblastoma than in patients without the disease. The three SNPs were clustered in the 6p22 region of chromosome 6. There are two genes in this region, but exactly what they do is unknown, the researchers said.

To confirm their findings, Maris' group analyzed blood samples from additional neuroblastoma patients and children without the disease. Among these additional patients, the researchers also found that variants in the 6p22 region were associated with increased risk for neuroblastoma.

"This finding gives us the motivation to continue this line of research to discover all of the different genetic variations that work together," Maris said. "We have already discovered additional variations."

Knowing the complete genetic influences on neuroblastoma may eventually lead to new treatments, he said.

Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society, said that the new findings could one day lead to better diagnosis and treatment of the malignancy. "We still need to understand what these genes do, because little is known about these genes," he said.

Lichtenfeld added that, while the new research is important, it's still very preliminary. "Ultimately, what you want to do is to analyze the cancer and gain clues as to what the prognosis may be and what the appropriate treatment may be," he said. "This does not get us there, but it is one step along that pathway."

More information

For more on neuroblastoma, visit the American Cancer Society.

SOURCES: John M. Maris, M.D., director of the Center for Childhood Cancer Research, The Children's Hospital of Philadelphia; Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society, Atlanta; May 7, 2008, New England Journal of Medicine, online

Copyright © 2008 ScoutNews, LLC. All rights reserved.

Customer Care - 1-888-632-5353 Toll Free

  
Additional Articles
Primary Tumors Fuel Growth of Cancer...
Facility Characteristics Influence...
DNA Coding May Make Bowel Prone to...
Raloxifene Cuts Risk of Certain Type of...
Researchers Update Risk-of-Death Charts
Medicare Costs for Cancer Treatment...
Decline in Cigarette Sales Offset by of...
Family History Plays Role in Black...
Blood Cancer Drug Shows Promise Against...
Method for Treating Cervical Lesions...
Fruits, Vegetables, Teas May Cut Risk...
Diabetes Boosts Liver Cancer Risk in...
Family History Might Improve Odds Colon...
Androgen Production Continues in Cancer...
Dangerous Side Effect Found in Cancer...
Chronic Stomach Inflammation Boosts...
Smokers With Colon Cancer Face High...
Black Cancer Patients Choose More Care...
Vaccine May Boost Survival of Brain...
U.S. Childhood Cancers Vary by Sex,...
3-Drug Combo Improves Advanced Cancer...
Erbitux Works Well for Two-Thirds of...
Anemia Drugs May Speed Tumor Growth in...
Combo Therapy Knocks Out Melanoma...
Celebrex May Reduce Levels of Lung...
Acupuncture Eases Side Effects of Head,...
Young Hodgkin Survivors Face Later Risk...
Erbitux Plus Chemo Improves Lung Cancer...
New Hope for Tough-to-Treat Cancers
Hodgkin Lymphoma Kids Face Greater Risk...
Avastin Added to Chemo Helps Women With...
Avastin Added to Chemo Helps Women With...
Bone Drug Lowers Risk of Breast Cancer...
Chemo May Limit Fertility in Breast...
Certain Tests in ERs Raise Cancer Risk...
Initiative Links Celebrities to Cancer...
Type of Tomato Product Determines Power...
Paclitaxel Plus Chemo Improves Outcomes...
Cancer Patients Should Steer Clear of...
Common Genetic Variant Tied to Lung...

Add to Google MSN Cancer
 Add Cancer
 To My Yahoo  Subscribe with Bloglines   Subscribe in NewsGator Online Cancer
 News Feed

The materials and articles published on DentalPlans.com are for informational purposes only. Although DentalPlans.com strives to be accurate and complete, the information is provided without liability for errors. DentalPlans.com does not warrant the accuracy or completeness of the information, text graphics, links, or other items contained on DentalPlans.com.

DentalPlans.com expressly disclaims liability for errors or omissions in these materials and DentalPlans.com makes no commitment to update the information on DentalPlans.com.

DentalPlans.com expressly disclaims all liability for the use or interpretation by others of information on DentalPlans.com. Decisions based on information contained on DentalPlans.com are the sole responsibility of the visitors, and visitors agree to hold DentalPlans.com and its Affiliates harmless against any claims for damages arising from decisions visitors make on such information.

Nothing on DentalPlans.com constitutes medical advice or other forms of advice. DentalPlans.com assumes no responsibility for material created or published by third parties linked to DentalPlans.com with or without DentalPlans.coms knowledge.

Let's Get Connected
Like Us on Facebook Follow Us on Twitter DentalPlans.com Blog, Dental Insurance Alternatives View Our YouTube Channel
Email Me Savings & Updates
Submit
Privacy Policy
The DENTALPLANS.COM website is administered by DENTALPLANS.COM, INC., a licensed Florida Discount Medical Plan Organization, 8100 S.W. 10th Street Suite #2000, Plantation, FL 33324. Plans and Programs offered by DentalPlans.com are not health insurance policies. Plans and Programs offered by DentalPlans.com provide discounts at certain health care providers for medical services. Plans and Programs offered by DentalPlans.com do not make payments directly to the providers of medical services. The Plan or Program member is obligated to pay for all health care services but will receive a discount from those health care providers who have contracted with the Plan, Program or discount plan organization.
Special promotions including but not limited to additional months free and Membership Rewards® points from American Express are not available to California residents.

© 1999-2011 DentalPlans.com, Inc. All Rights Reserved. Patents Pending. Blue Cross and Blue Shield of Florida is an Independent Licensee of the Blue Cross and Blue Shield Association.
BBB Rating A+    McAfee SECURE sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams